Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by David Boulware and Sylvain Lother.
David Boulware
Connection Strength
1.601
Sylvain Lother
  1. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial. Can J Anaesth. 2020 09; 67(9):1201-1211.
    View in: PubMed
    Score: 0.881
  2. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial. Ann Intern Med. 2020 10 20; 173(8):623-631.
    View in: PubMed
    Score: 0.223
  3. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 08 06; 383(6):517-525.
    View in: PubMed
    Score: 0.221
  4. Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19). Open Forum Infect Dis. 2020 Apr; 7(4):ofaa130.
    View in: PubMed
    Score: 0.219
  5. Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa500.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.